Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma
- PMID: 17908805
- DOI: 10.1136/jcp.2007.050666
Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma
Abstract
Background: Hypoxia inducible factor (HIF)-1alpha is a critical regulatory protein of cellular response to hypoxia and is closely related to angiogenic process.
Aims: To explore the potential role and the prognostic value of HIF-1alpha in urothelial carcinoma (UC).
Methods: Clinicopathological and follow-up data on 99 UC cases were reviewed and immunostained for HIF-1alpha, CD68, vascular endothelial growth factor (VEGF) and CD34 antigen. Tumour-associated macrophage (TAM) counts and HIF-1alpha expression were compared with clinicopathologic characteristics, overall survival (OS) and disease-free survival rates (DFS).
Results: High expression of HIF-1alpha was detected in 55 of 99 (55.6%) tumours. HIF-1alpha expression was correlated with tumour size, histological grade, tumour invasiveness and recurrence. VEGF and microvessel density (MVD) demonstrated their positive correlation with HIF-1alpha overexpression, supporting the correlation of HIF-1alpha up-regulation with tumour angiogenesis. Higher TAM infiltration was identified in high expression of HIF-1alpha cases rather than HIF-1alpha low expression cases (p = 0.002). Kaplan-Meier analysis found that HIF-1alpha overexpression and high TAM count was only associated with worse DFS (p = 0.009, p = 0.023) but was not associated with OS (p = 0.696, p = 0.141). Multivariate analyses indicated only tumour size (p = 0.038) to be an independently significant prognostic factor for OS, in addition, HIF-1alpha expression (p = 0.011), as well as histological grade (p = 0.038), and MVD (p = 0.004), to be independently significant prognostic factors for DFS.
Conclusions: Our results indicate that HIF-1alpha is a key regulator of the angiogenic cascade. We show that HIF-1alpha is an independent prognostic factor for disease-free survival.
Similar articles
-
Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.Eur Urol. 2004 Aug;46(2):200-8. doi: 10.1016/j.eururo.2004.04.008. Eur Urol. 2004. PMID: 15245814
-
Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.BJU Int. 2005 Feb;95(3):425-31. doi: 10.1111/j.1464-410X.2005.05314.x. BJU Int. 2005. PMID: 15679808
-
Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.APMIS. 2009 Mar;117(3):176-84. doi: 10.1111/j.1600-0463.2008.00004.x. APMIS. 2009. PMID: 19245590
-
Angiogenesis, angiogenic factor expression and prognosis of bladder cancer.Anticancer Res. 2001 Nov-Dec;21(6B):4355-63. Anticancer Res. 2001. PMID: 11908691 Review.
-
Hypoxia-inducible factor 1alpha in oral cancer.J Oral Pathol Med. 2005 Aug;34(7):385-9. doi: 10.1111/j.1600-0714.2005.00335.x. J Oral Pathol Med. 2005. PMID: 16011605 Review.
Cited by
-
Role of angiogenesis in urothelial bladder carcinoma.Cent European J Urol. 2016;69(3):258-263. doi: 10.5173/ceju.2016.830. Epub 2016 Jul 13. Cent European J Urol. 2016. PMID: 27729991 Free PMC article. Review.
-
Myeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression.Cancer Microenviron. 2010 Apr 20;4(1):1-11. doi: 10.1007/s12307-010-0045-4. Cancer Microenviron. 2010. PMID: 21505557 Free PMC article.
-
Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.Br J Cancer. 2014 Jul 29;111(3):437-43. doi: 10.1038/bjc.2014.315. Epub 2014 Jun 17. Br J Cancer. 2014. PMID: 24937673 Free PMC article.
-
The effect of hypoxia on PD-L1 expression in bladder cancer.BMC Cancer. 2021 Nov 25;21(1):1271. doi: 10.1186/s12885-021-09009-7. BMC Cancer. 2021. PMID: 34819027 Free PMC article.
-
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.Bladder Cancer. 2016 Jan 7;2(1):101-109. doi: 10.3233/BLC-150033. Bladder Cancer. 2016. PMID: 27376131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical